- Home
- PLX vs PCSC Comparison
PLX vs PCSC Comparison
Compare PLX & PCSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLX
- PCSC
- Stock Information
- Founded
- PLX 1993
- PCSC 2024
- Country
- PLX United States
- PCSC United States
- Employees
- PLX N/A
- PCSC N/A
- Industry
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- PCSC
- Sector
- PLX Health Care
- PCSC
- Exchange
- PLX Nasdaq
- PCSC NYSE
- Market Cap
- PLX 122.6M
- PCSC 114.2M
- IPO Year
- PLX 1998
- PCSC 2024
- Fundamental
- Price
- PLX $1.40
- PCSC $10.70
- Analyst Decision
- PLX Strong Buy
- PCSC
- Analyst Count
- PLX 1
- PCSC 0
- Target Price
- PLX $15.00
- PCSC N/A
- AVG Volume (30 Days)
- PLX 640.7K
- PCSC 6.7K
- Earning Date
- PLX 08-13-2025
- PCSC 01-01-0001
- Dividend Yield
- PLX N/A
- PCSC N/A
- EPS Growth
- PLX N/A
- PCSC N/A
- EPS
- PLX 0.05
- PCSC N/A
- Revenue
- PLX $59,764,000.00
- PCSC N/A
- Revenue This Year
- PLX $65.02
- PCSC N/A
- Revenue Next Year
- PLX $57.34
- PCSC N/A
- P/E Ratio
- PLX $28.96
- PCSC $46.48
- Revenue Growth
- PLX 0.18
- PCSC N/A
- 52 Week Low
- PLX $0.82
- PCSC $10.02
- 52 Week High
- PLX $3.10
- PCSC $10.74
- Technical
- Relative Strength Index (RSI)
- PLX 30.38
- PCSC N/A
- Support Level
- PLX $1.52
- PCSC N/A
- Resistance Level
- PLX $1.65
- PCSC N/A
- Average True Range (ATR)
- PLX 0.08
- PCSC 0.00
- MACD
- PLX 0.02
- PCSC 0.00
- Stochastic Oscillator
- PLX 17.19
- PCSC 0.00
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About PCSC PERCEPTIVE CAP SOLUTIONS CORP
Perceptive Capital Solutions Corp is a blank check company.